Association between treatment-emergent cytopenias and clinical responses to imetelstat in lower-risk myelodysplastic syndromes - Top-Institutions - MDSpire

Association between treatment-emergent cytopenias and clinical responses to imetelstat in lower-risk myelodysplastic syndromes

  • By

  • Amer M. Zeidan

  • Valeria Santini

  • María Díez-Campelo

  • Michael R. Savona

  • Mikkael A. Sekeres

  • Yazan F. Madanat

  • Pierre Fenaux

  • Azra Raza

  • Moshe Mittelman

  • Sylvain Thépot

  • Rena Buckstein

  • Ulrich Germing

  • David Valcárcel

  • Anna Jonášová

  • Sheetal Shah

  • Qi Xia

  • Libo Sun

  • Shyamala Navada

  • Tymara Berry

  • Uwe Platzbecker

  • Rami S. Komrokji

  • April 7, 2026

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Hematology
    • Oncology
    • Myelodysplastic Syndromes

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology
    • Oncology
    • Myelodysplastic Syndromes

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hematology
    • Oncology
    • Myelodysplastic Syndromes

  • #4

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematology
    • Oncology
    • Stem Cell Transplantation

  • #5

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology
    • Oncology
    • Myelodysplastic Syndromes

Original Source(s)

Association between treatment-emergent cytopenias and clinical responses to imetelstat in lower-risk myelodysplastic syndromes

  • by Amer M. Zeidan, Valeria Santini, María Díez-Campelo, Michael R. Savona, Mikkael A. Sekeres, Yazan F. Madanat, Pierre Fenaux, Azra Raza, Moshe Mittelman, Sylvain Thépot, Rena Buckstein, Ulrich Germing, David Valcárcel, Anna Jonášová, Sheetal Shah, Qi Xia, Libo Sun, Shyamala Navada, Tymara Berry, Uwe Platzbecker, Rami S. Komrokji

  • April 7, 2026

Related Content

Clinical Findings in Migrants With Asymptomatic Plasmodium Infections

Clinical Reasoning in Practice: Implementing High-Value Care When Data Discrepancies Arise

Molecular Identification of HTLV-1 and HCV Infections in Sickle Cell Disease Patients Undergoing Multiple Transfusions in Kinshasa: A Case Study of CMMASS